Pancreatic Cancer Research

ResearcherAristotle University of ThessalonikiActive in the last 2 years

Paul Zarogoulidis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5119-2207; OpenAlex author ID A5037835689. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Prognostic significance of BRCA1 and BRCA2 methylation status in circulating cell-free DNA of Pancreatic Cancer patients. Co-author DOI 10.7150/jca.93184↗
  2. Pancreatic cancer from bench to bedside: molecular pathways and treatment options. Co-author DOI 10.21037/atm.2016.05.11↗
  3. Current and future intratumoral targeted treatment for pancreatic cancer. Co-author DOI 10.4155/tde.14.44↗
  4. Molecular pathogenesis of pancreatic cancer and clinical perspectives. First author DOI 10.1159/000334449↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stylianos Kakolyris · 3 shared papers, 2011–2024 · strength 0.26
  2. Dimitrios Matthaios · 2 shared papers, 2011–2024 · strength 0.22
  3. Anastasios J. Karayiannakis · 1 shared paper, 2024 · strength 0.19
  4. Triantafyllia Koukaki · 1 shared paper, 2024 · strength 0.19
  5. John Kanellos · 1 shared paper, 2016 · strength 0.06
  6. Christoforos S. Kosmidis · 1 shared paper, 2016 · strength 0.06
  7. Yan-Gao Man · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.